Healio brings you the highlights from the Vascular Intervention Advances Scientific Session. Refer back to this page often for the latest news from VIVA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

DANCE-ATX: Dexamethasone micro-infusion beneficial in atherectomy

October 3, 2017
LAS VEGAS — Adventitial drug delivery with dexamethasone conferred positive 2-year outcomes in patients with peripheral artery disease who…
Meeting NewsPerspective

With newer technologies, EVAR outcomes do not differ by sex

October 2, 2017
Two newer technologies for endovascular aneurysm repair conferred similar outcomes for men and women, according to presentations at VIVA 17…
Meeting News

Percutaneous system for access-site closure beneficial vs. surgical cutdown

September 29, 2017
LAS VEGAS — Percutaneous closure of large-bore arterial access sites was associated with positive outcomes compared with surgical cutdown…
Meeting News

PREVEIL: Novel DCB shows feasibility in first-in-human study

September 27, 2017
A first-in-human trial of a novel drug-coated balloon showed technical and performance success, according to findings presented at VIVA 17. Gary M
Meeting News

DETOUR I: Percutaneous bypass procedure successful in long peripheral lesions

September 22, 2017
A novel percutaneous bypass system using the femoral vein as a pathway conferred a high rate of patency with no effect on venous health in patients…
Meeting News

AcoArt I: Novel DCB successfully treats femoropopliteal disease at 2 years

September 20, 2017
A novel drug-coated balloon was associated with higher rates of patency and lower rates of target lesion revascularization at 2 years vs…
Meeting NewsPerspective

SAFE-DCB: High procedural success, few events in DCB registry

September 18, 2017
According to an interim analysis from a registry presented at VIVA 17, a drug-coated balloon was safe and effective at 12 months. Edward
Meeting NewsPerspective

ILLUMENATE: DCB yields durable treatment effect at 2 years

September 14, 2017
LAS VEGAS — New data from the ILLUMENATE EU randomized controlled trial demonstrate higher primary patency and a lower rate of clinically…
Meeting NewsPerspective

ACT 1: Carotid stenting beneficial in women, heavy atherosclerotic burden

September 13, 2017
LAS VEGAS — Two subanalyses of the ACT 1 trial found carotid artery stenting benefited women and patients with the worst atherosclerotic burden…
Meeting News

DCB beneficial in hemodialysis arteriovenous fistulae lesions

September 13, 2017
LAS VEGAS — In patients with dysfunctional hemodialysis arteriovenous fistulae, adding a drug-coated balloon to treatment with percutaneous…

Meeting Calendar


September 11, 2017 - September 15, 2017

  • Location: Las Vegas, Nev.
Healio Jobs